4 completed. 2 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Mepha Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed Administration 40 mg Esomeprazole Mepha (Mepha Ltd., Switzerland), INexium 40 mg MUPS tablets (AstraZeneca, France) - Healthy | Phase 1 | Completed | Mepha Ltd. | 100 | 2009-04-01 | 2009-06-23 |
| Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria artesunate and mefloquine - Malaria | Phase 4 | Completed | Mepha Ltd. | 220 | 2007-12-01 | 2009-09-16 |
| Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults Nitrofurantoin - Urinary Tract Infection | Phase 4 | Completed | Mepha Ltd. | 37 | 2007-01-01 | 2010-03-24 |
| Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria Artesunate-Mefloquine - Malaria | Phase 2 | Completed | Albert Schweitzer Hospital | 70 | 2005-10-01 | 2013-01-24 |
Malaria (2) · Urinary Tract Infections (1)
Artesunate (1) · Mefloquine (1) · Nitrofurantoin (1) · major urinary proteins (1)
Cameroon (1) · Gabon (1) · Germany (1) · Mexico (1)
Arturo Mendoza Valdes, MD (1) · Felix Tietche, Prof (1) · Frank Donath, MD (1) · Maryvonne Kombila, Prof Dr (1)